PlexBio Co. Ltd

Detailed Description

PlexBio Co., Ltd. designs, develops, and manufactures multiplexing platforms and assays to enable genetic research and clinical cancer diagnostics. It offers IntelliPlex SARS-CoV-2/Flu Kit, an in vitro diagnostic device; IntelliPlex SARS-CoV-2 Detection Kit, an automated solution for testing during the coronavirus disease; IntelliPlex Lung Cancer Panel-cfDNA, a molecular assay for mutations; IntelliPlex Lung Cancer Panel – cfRNA, which detects various variants of the ALK, ROS1, RET, NTRK1, and MET genes using cell-free RNA derived from plasma of patients with NSCLC; IntelliPlex Lung Cancer Panel, which detects various DNA mutations; IntelliPlex BRAF V600 Mutation Kit, a single well solution for mutations; IntelliPlex EGFR Mutation Kit, a molecular assay for somatic mutations; IntelliPlex KRAS Mutation Plus Kit, a solution for clinically actionable mutations; IntelliPlex NRAS Mutation Kit, a single well mutation kit; IntelliPlex PIK3CA Mutation Kit, a PCR mutation kit; IntelliPlex ALK Rearrangement Kit, a single well solution for actionable ALK gene rearrangements; IntelliPlex RET/NTRK1 Rearrangement Kit, a single well RET and NTRK1 gene rearrangement kit; IntelliPlex ROS1 Rearrangement Kit, a molecular assay for clinical actionable gene rearrangements; IntelliPlex Food Testing Kit for Dairy, a single well solution for bacteria; and pCode Coupling Buffer Set, a solution for coupling process. The company also offers IntelliPlex 1000 pCode Processor, a hybridization, washing, incubation, and labeling solution; PlexBio 100 Fluorescent Analyzer, an optical imaging system; DigiPlex Thermocycler, an instrument for PCR amplification; pCode MicroDisc, a solution for multiplexing applications; PlexBio Magnetic Stand, a solution for paramagnetic pCode precipitation; pCode Coupling Buffer Set, a solution to-use buffers; and DeXipher software for data analysis and interpretation. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei City, Taiwan.